[Which antipsychotic as first choice in schizophrenia? The Dutch Multidisciplinary Guideline for Schizophrenia 2005 versus the Pharmacotherapy Compass 2005, the Dutch National Health Insurance System Formulary].
The pharmacotherapy advice contained in the 'Multidisciplinaire Richtlijn Schizofrenie 2005' (abbreviated to MDRS 2005 and translated as the Dutch Multidisciplinary Schizophrenia Guideline) is compared with the advice given in the 'Farmacotherapeutisch Kompas 2005' (abbreviated to FTK 2005 and translated as the Pharmacotherapy Compass 2005) and with international guidelines. FTK 2005, which is the Dutch National Health Insurance Formularium, recommends that treatment should start with a conventional (first-generation) antipsychotic, namely haloperidol. International guidelines, however, advise starting with an atypical (second-generation) antipsychotic. MDRS 2005 suggests that the pros and cons of the medication should be discussed with the patient and that the choice of drug should be based on the outcome of this discussion. Ifthat discussion becomes problematical then, according to MD RS 2005, it is advisable
Harms
H H
HH
De Geestgronden te Bennebroeck.
D014150:Antipsychotic Agents / Q000627:therapeutic use*; D006220:Haloperidol / Q000627:therapeutic use; D006291:Health Policy; D006801:Humans; D009426:Netherlands; D017410:Practice Guidelines as Topic / Q000592:standards; D011570:Psychiatry / Q000592:standards*; D011618:Psychotic Disorders / Q000188:drug therapy*; D012565:Schizophrenic Psychology
D014150:Antipsychotic Agents; D006220:Haloperidol